Condition: Attention Deficit/Hyperactivity Disorder · Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
To evaluate long-term safety exposure
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Harmonex Neuroscience Research | Dothan, Alabama, United States | — |
| The Center for Clinical Trials, Inc. | Saraland, Alabama, United States | — |
| Southwest Autism Research and Resource Center | Phoenix, Arizona, United States | — |
| Preferred Research Partners, Inc. | Little Rock, Arkansas, United States | — |
| Woodland International Research Group | Little Rock, Arkansas, United States | — |
| Care Access | Beverly Hills, California, United States | — |
| Proscience Research Group | Culver City, California, United States | — |
| Sun Valley Research Center, Inc. | Imperial, California, United States | — |
| Long Beach Clinical Trials Services, Inc | Long Beach, California, United States | — |
| NRC Research Institute | Orange, California, United States | — |
| SDS Clinical Trials Inc | Santa Ana, California, United States | — |
| CMB Clinical Trials | Santee, California, United States | — |
+ 74 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.